Inspire Medical (INSP) | Financial Analysis & Statements
Inspire Medical Systems, Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
269.1M
Gross Profit
233.0M
86.59%
Operating Income
46.1M
17.14%
Net Income
136.1M
50.58%
EPS (Diluted)
$4.66
Balance Sheet Metrics
Total Assets
907.3M
Total Liabilities
126.2M
Shareholders Equity
781.2M
Debt to Equity
0.16
Cash Flow Metrics
Operating Cash Flow
131.2M
Free Cash Flow
41.8M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Inspire Medical Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 912.0M | 802.8M | 624.8M | 407.9M | 233.4M |
| Cost of Goods Sold | 133.2M | 123.0M | 96.6M | 66.1M | 33.3M |
| Gross Profit | 778.8M | 679.8M | 528.2M | 341.7M | 200.1M |
| Gross Margin % | 85.4% | 84.7% | 84.5% | 83.8% | 85.7% |
| Operating Expenses | |||||
| Research & Development | 103.2M | 114.1M | 116.5M | 68.6M | 37.4M |
| Selling, General & Administrative | 624.6M | 529.6M | 452.0M | 320.7M | 202.6M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 727.8M | 643.7M | 568.5M | 389.3M | 240.0M |
| Operating Income | 51.0M | 36.1M | -40.3M | -47.6M | -39.8M |
| Operating Margin % | 5.6% | 4.5% | -6.4% | -11.7% | -17.1% |
| Non-Operating Items | |||||
| Interest Income | 17.5M | 23.2M | 20.6M | 5.0M | 125.0K |
| Interest Expense | 137.0K | 22.0K | 0 | 1.7M | 2.1M |
| Other Non-Operating Income | -2.7M | -855.0K | -195.0K | -49.0K | -117.0K |
| Pre-tax Income | 65.7M | 58.5M | -19.9M | -44.3M | -42.0M |
| Income Tax | -79.7M | 4.9M | 1.2M | 613.0K | 72.0K |
| Effective Tax Rate % | -121.4% | 8.5% | 0.0% | 0.0% | 0.0% |
| Net Income | 145.4M | 53.5M | -21.2M | -44.9M | -42.0M |
| Net Margin % | 15.9% | 6.7% | -3.4% | -11.0% | -18.0% |
| Key Metrics | |||||
| EBITDA | 79.8M | 65.0M | -17.1M | -40.7M | -38.6M |
| EPS (Basic) | - | $1.80 | $-0.72 | $-1.60 | $-1.54 |
| EPS (Diluted) | - | $1.75 | $-0.72 | $-1.60 | $-1.54 |
| Basic Shares Outstanding | - | 29763395 | 29302154 | 28071748 | 27262979 |
| Diluted Shares Outstanding | - | 29763395 | 29302154 | 28071748 | 27262979 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Inspire Medical Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 104.8M | 150.2M | 185.5M | 441.6M | 214.5M |
| Short-term Investments | 203.5M | 295.4M | 274.8M | 9.8M | 0 |
| Accounts Receivable | 119.7M | 93.1M | 89.9M | 61.2M | 34.2M |
| Inventory | 145.3M | 80.1M | 33.9M | 11.9M | 17.2M |
| Other Current Assets | 10.4M | 12.1M | 9.6M | 5.5M | 2.7M |
| Total Current Assets | 583.7M | 630.8M | 593.7M | 530.0M | 268.5M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 54.2M | 34.1M | 9.1M | 6.5M | 12.6M |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 105.9M | 11.3M | 11.3M | 10.7M | 204.0K |
| Total Non-Current Assets | 323.7M | 177.6M | 83.1M | 34.8M | 26.5M |
| Total Assets | 907.3M | 808.4M | 676.8M | 564.9M | 295.1M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 36.6M | 38.7M | 38.8M | 26.8M | 11.7M |
| Short-term Debt | 2.2M | 1.8M | - | 1.3M | 9.5M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 96.1M | 88.5M | 78.1M | 61.2M | 41.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 30.0M | 30.0M | 24.8M | 7.5M | 24.6M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 104.0K | 148.0K | 1.3M | 146.0K | 134.0K |
| Total Non-Current Liabilities | 30.1M | 30.2M | 26.2M | 7.7M | 24.7M |
| Total Liabilities | 126.2M | 118.7M | 104.3M | 68.9M | 66.0M |
| Equity | |||||
| Common Stock | 29.0K | 30.0K | 30.0K | 29.0K | 27.0K |
| Retained Earnings | -146.5M | -291.9M | -345.4M | -324.3M | -279.4M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 781.2M | 689.7M | 572.5M | 496.0M | 229.0M |
| Key Metrics | |||||
| Total Debt | 32.2M | 31.8M | 24.8M | 8.9M | 34.1M |
| Working Capital | 487.6M | 542.3M | 515.6M | 468.8M | 227.2M |
Balance Sheet Composition
Inspire Medical Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 145.4M | 53.5M | -21.2M | -44.9M | -42.0M |
| Depreciation & Amortization | 14.0M | 6.6M | 2.8M | 1.9M | 1.2M |
| Stock-Based Compensation | 130.3M | 116.0M | 82.5M | 52.0M | 26.2M |
| Working Capital Changes | -95.2M | -48.2M | -42.9M | -7.3M | -13.2M |
| Operating Cash Flow | 107.8M | 129.4M | 25.0M | 2.4M | -26.5M |
| Investing Activities | |||||
| Capital Expenditures | -38.5M | -39.1M | -23.6M | -9.1M | -4.7M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -250.4M | -418.6M | -281.4M | -10.5M | -10.0M |
| Investment Sales | 310.4M | 344.6M | 10.2M | 0 | 43.8M |
| Investing Cash Flow | 21.4M | -113.1M | -294.8M | -19.6M | 29.1M |
| Financing Activities | |||||
| Share Repurchases | -175.0M | -75.0M | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | 0 | 0 | -24.5M | 0 |
| Financing Cash Flow | -198.1M | -80.2M | -17.2M | 219.3M | 0 |
| Free Cash Flow | 78.5M | 91.1M | 1.0M | 2.5M | -24.8M |
| Net Change in Cash | -68.8M | -63.9M | -287.0M | 202.1M | 2.6M |
Cash Flow Trend
Inspire Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
10.64
Forward P/E
20.13
Price to Book
1.90
Price to Sales
1.64
PEG Ratio
0.04
Profitability Ratios
Profit Margin
15.95%
Operating Margin
17.14%
Return on Equity
19.77%
Return on Assets
3.71%
Financial Health
Current Ratio
6.08
Debt to Equity
4.12
Beta
0.86
Per Share Data
EPS (TTM)
$4.89
Book Value per Share
$27.33
Revenue per Share
$31.05
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| INSP | 1.6B | 10.64 | 1.90 | 19.77% | 15.95% | 4.12 |
| Abbott Laboratories | 160.7B | 25.97 | 3.09 | 12.36% | 13.90% | 26.79 |
| Stryker | 126.3B | 39.21 | 5.62 | 15.08% | 12.92% | 72.97 |
| Axogen | 1.9B | -110.18 | 13.15 | -13.49% | -6.97% | 55.50 |
| Establishment Labs | 1.9B | -37.89 | 79.68 | -133.25% | -24.19% | 1,123.15 |
| Artivion | 1.8B | 179.71 | 4.03 | 2.70% | 2.21% | 57.67 |
Financial data is updated regularly. All figures are in the company's reporting currency.






